Owned and operated by a cf veteran 
Independent analytical report
Retatrutide 20 mg — Task 100126
Review the report details, original PDF and Janoshik verification record.
Report summary
- Compound
- Retatrutide
- Strength
- 20 mg
- Reported purity
- 99.575%
- Tested quantity
- 21.54 mg
- Report date
- January 29, 2026
- Janoshik task ID
- #100126
Submitted January 2026 and analysed on the 29th, this certificate reports 21.54 mg of Retatrutide at 99.575 percent purity.
The order was placed as a common GLP-1 blind test, meaning the laboratory screened for Semaglutide and Tirzepatide alongside Retatrutide without being told which was expected. It is the earlier of two analytical records for the 20 mg presentation and remains published as history.
This certificate describes the submitted sample identified in the report. It does not establish clinical safety, efficacy, suitability for human or veterinary use, or the specifications of future inventory.